Announcements Trials
Browse Landscape

Phase

Phase 2 32Phase 1 6Phase NA 4Phase EARLY_PHASE1 3Phase 4 3Phase 3 3Phase 1/2 1

Status

Completed 19Unknown 9Recruiting 4Terminated 3Withdrawn 2Not yet recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Motor Activity 1Metabolic Syndrome 1Insulin Resistance 1Hepatitis C, Chronic 1Fibrosis 1Death 1Carcinoma, Hepatocellular 1Body Weight 1

Interventions

Cisplatin 62Carboplatin 52Paclitaxel 48Radiotherapy 47Docetaxel 41Gemcitabine 38Cyclophosphamide 36Rituximab 33Capecitabine 28Fluorouracil 27Dexamethasone 27Doxorubicin 26Prednisone 21Bevacizumab 20Pemetrexed 19Oxaliplatin 18Leucovorin 18pembrolizumab 17Vincristine 17Etoposide 17Cytarabine 15Drug Therapy 14Irinotecan 13Imatinib Mesylate 13Filgrastim 13Zoledronic Acid 12Radiosurgery 12Erlotinib Hydrochloride 12Trastuzumab 11Goserelin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Terminated × Metformin × Clear all
NCT03031821 2024-10-04

PRIME

Canadian Urologic Oncology Group

Phase 3 Terminated
168 enrolled
Genitourinary

Prostatic Neoplasms, Metabolic Syndrome

NCT01482286 2022-03-15

PULSE

Pennington Biomedical Research Center

Phase 3 Terminated
32 enrolled 10 charts

Body Weight, Insulin Resistance, Motor Activity, Polycystic Ovary Syndrome

NCT02319200 2017-01-11

METFOVIR

Assistance Publique - Hôpitaux de Paris

Phase 3 Terminated
11 enrolled
Gastrointestinal

Death, Fibrosis, Carcinoma, Hepatocellular, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡